A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-α2B in patients with metastatic melanoma

Michael B. Atkins, Jared A. Gollob, Jeffrey A. Sosman, David F. McDermott, Linda Tutin, Patricia Sorokin, Robert A. Parker, James W. Mier

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint Dive into the research topics of 'A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-α2B in patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences